Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
271,601
-
Shares change
-
+26,965
-
Total reported value, excl. options
-
$1,618,000
-
Value change
-
+$160,786
-
Number of buys
-
10
-
Number of sells
-
-3
-
Price
-
$5.95
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q3 2015
16 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q3 2015.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 271,601 shares
.
Largest 10 shareholders include HealthInvest Partners AB (108,750 shares), RENAISSANCE TECHNOLOGIES LLC (45,200 shares), SHUFRO ROSE & CO LLC (40,191 shares), Essex Financial Services, Inc. (23,776 shares), Minerva Advisors LLC (14,559 shares), VANGUARD GROUP INC (11,975 shares), GRT CAPITAL PARTNERS L.L.C. (11,475 shares), MORGAN STANLEY (5,000 shares), UBS Group AG (2,963 shares), and Walleye Trading LLC (2,100 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.